What question did this study set out to answer?

This research aims to assess the feasibility of RNA sequencing on FFPE tissues and improve molecular classification of ovarian cancer.

March 23, 2026Open Access

Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort

Key Points

This research aims to assess the feasibility of RNA sequencing on FFPE tissues and improve molecular classification of ovarian cancer.
Utilized RNA sequencing (RNAseq) on formalin-fixed paraffin-embedded (FFPE) ovarian cancer tissues.
Analyzed transcriptomic data to identify potential prognostic gene candidates.
Compared RNAseq findings with microarray-based transcriptomic classification tools.
Identified potential prognostic gene candidates through transcriptomic analysis.
Highlighted challenges related to applying microarray classifications to RNAseq data.
Recommended refinement of molecular classification tools for better accuracy.

Abstract

This study demonstrates the feasibility of using RNAseq on FFPE tissue in EOC, while also highlighting challenges of applying microarray-based transcriptomic subtypes to RNAseq data. Transcriptomic analysis identified potential prognostic gene candidates but also highlighted the need to refine classification tools. Further research is essential to improve the molecular classification of EOC, thereby enhancing prognostic accuracy and guiding future therapeutic strategies.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Kjeldsen et al. (Thu,) studied this question.

synapsesocial.com/papers/69c0ddb8fddb9876e79c111d https://doi.org/https://doi.org/10.1016/j.tranon.2026.102740

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper